SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001437749-21-021128
Filing Date
2021-08-30
Accepted
2021-08-30 10:27:10
Documents
2
Group Members
E&HEALTHCARE INVESTMENT FUND IIE&HEALTHCARE INVESTMENT FUND NO. 6E&HEALTHCARE INVESTMENT FUND NO. 7NA YEON KIM

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A einv20210829_sc13da.htm SC 13D/A 103696
2 EXHIBIT C ex_279840.htm EX-99.C 55487
  Complete submission text file 0001437749-21-021128.txt   161023
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Subject) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89598 | Film No.: 211221543
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16TH FLOOR, YEOKSAM I-TOWER B/D 326, TEHERAN-RO, GANGNAM-GU SEOUL M5 00000
Business Address 16TH FLOOR, YEOKSAM I-TOWER B/D 326, TEHERAN-RO, GANGNAM-GU SEOUL M5 00000 82-2-501-3714
E&Investment, Inc. (Filed by) CIK: 0001796144 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A